← All supplements
Limited evidenceHeart & metabolic

D-Pinitol

A methylated inositol found in carob and soy, proposed to act as an insulin second messenger. Small human trials give mixed results: some show a lower glucose response, one found no change in glucose tolerance at all.

Evidence last reviewed: August 2026

What the science says

  • Acute post-meal glucose Limited evidence

    A randomized trial found a single acute dose of pinitol from a natural food ingredient lowered post-load glucose and insulin in healthy subjects. It was an acute, single-dose study in a small group.

  • Insulin sensitivity with continued use Limited evidence

    A randomized controlled trial of chronic consumption of an inositol-enriched carob extract reported improved postprandial glycaemia and insulin sensitivity in healthy subjects over several weeks. The sample was small and the participants were not diabetic.

  • Glucose tolerance in older adults Limited evidence

    A randomized study of acute pinitol supplementation in older humans raised plasma pinitol but did not improve whole-body glucose tolerance or skeletal muscle insulin receptor activation. This negative result tempers the positive trials.

Dosage & safety

Studied doseHuman studies used roughly 0.6–4 g per day, often as a single acute dose of about 1–2 g before a carbohydrate load. Supplement labels typically suggest 500–1000 mg daily.
SafetyShort-term studies report no notable adverse effects; digestive upset is possible at higher doses. Long-term safety is unstudied. People on insulin or sulfonylureas should monitor glucose because of the theoretical additive effect. Soy-derived products may matter for soy allergy.

Scientific references

Where to buy

Referral link — this site may earn a commission on purchases.

Related in Heart & metabolic